Exercise, new drug class recommended for management of hypertrophic cardiomyopathy
Wednesday, 8 May 2024 ()
Experts released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HCM). The guideline reiterates the importance of collaborative decision-making with patients who have HCM and provides updated recommendations for the most effective treatment pathways for adult and pediatric patients.
|
||||
|
|
||||
You Might Like |
||||
